Recently, Van Herk Ventures took a minority stake in Medis medical imaging systems bv, a cardiovascular imaging software company with global market representation and a 28 years history of innovations. Medis is a technology leader in high-accuracy image analytics in cardio-vascular imaging, with solutions that are vendor independent and cover all major cardiovascular imaging modalities.
Medis raised several millions through the investment by Van Herk Ventures. The investment will be used to accelerate sales and marketing and to strengthen R&D across all product, with an emphasis on Medis’ QFR®. The terms of the investment were not disclosed.
“We have been intrigued by the broad spectrum of innovations in the cardiovascular imaging domain that Medis has created and commercialized over the years, and in particular the more recent exciting and disruptive opportunities in the field of interventional cardiology. Medis has been recognized worldwide as a company that develops high quality software, listening to the needs of the clinicians and researchers and supporting them with new and expanded applications. We believe that there is a great upwards potential in Medis and we like to stimulate these developments and see the company grow to the next level” said Dharminder Chahal, Investment Manager of Van Herk Ventures.
“We are very pleased with the investment by Van Herk Ventures in Medis” said Prof. Hans Reiber, PhD., President and Chief Executive Officer of Medis. “Our recent breakthroughs in the field of physiologic assessment of coronary obstructions during the cardiac catheterization procedures with image-based QFR®, which is a cost-effective solution that applies to the global healthcare system, can now be further expanded and its worldwide commercialization accelerated thanks to these investments. In addition, our products in the fields of magnetic resonance and multi-slice CT will profit from technological investments in artificial intelligence (AI), cloud-based educational and training opportunities and many others”.
Medis is a leading medical technology company with focus on the development, validation, worldwide commercialization, and support of multi-vendor analytical software solutions in the cardiovascular domain, covering X-ray, IVUS, OCT, MRI as well as MSCT applications. It exists now 28 years after it spun off from the Leiden University Medical Center (LUMC) in the Netherlands. Its headquarters is in Leiden, the Netherland, with a subsidiary in Raleigh, USA, and branch offices in Tokyo, Japan, and Birmingham, UK. Medis has strategic collaborations with the LUMC, Shanghai Jiao Tong University and Pulse Medical Imaging Technology Co., Ltd. in Shanghai, China.
Van Herk Ventures is a part of the Rotterdam based Van Herk Groep (www.vanherkgroep.nl). Van Herk Groep was founded by Aat van Herk (1951) and holds a portfolio of investments in real estate, energy and life sciences. Van Herk Ventures invests in the life sciences sector through direct investments in private and listed companies and in venture capital funds.